Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Stem cells help control the immune response to improve wound healing.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Belatacept may be a promising treatment for alopecia areata.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Immune system changes may contribute to female pattern hair loss.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Treg cells help repair and regenerate tissues by interacting with local cells.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Different types of skin cells and immune cells play a role in healing UV-damaged skin, with chronic UV exposure causing lasting damage to certain skin cells.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.